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Abstract. The research undertaken during November 2008 - April 2009 was aimed to find the 
required pharmacological reference parameters in order to diagnosis the resistance phenomenon of 
equine strongyls. Strongyls eggs originated from a total of 126 faecal samples collected during the 6 
months of study on three different areas of the Danube Delta, where it is estimated that there are a 
number of over 4,000 wild untreated equine. Testing effectiveness of Mebendazole (MBZ), 
Fenbendazole (FBZ) and Ivermectine (IVM) was performed in vitro by larva development assay 
(LDA). To Fenbendazole the reference lethal concentrations were LC50 0.0089µg/ml; LC90 -
0.7430µg/ml and LC100 -0.9265µg/ml with a MIC of -18.6031µg/ml.  To Mebendazole the reference 
lethal concentrations were LC50 -0.0078µg/ml, LC90 -0.4566µg/ml and LC100 -0.5688µg/ml with a MIC 
of 21.4542µg/ml. To Ivermectine the reference parameters were LC50 -0.00028µg/ml, LC90 
0.0011µg/ml and LC100 0.0013µg/ml with a MIC of -250.004µg/ml. 
 




To determine the adaptive phenomena of strongyls from equine to anthelmintic 
medication mast calculate the resistance factor (RF). This factor is calculated based on a 
report between a resistant and sensitive parasite population based on LD50 value [Kelly and 
Hall, 1979]. The problem is finding some equine populations that have not received any 
anthelmintic treatment. For this reason, populations of strongyls should be free of mutations 
that enable them to adapt to the medication commonly used for deworming [Dorchies, 1991, 
Cernea, 2007]. The sensitive equine population was identified in the Danube Delta, in three 
different areas where it is estimated that there are over 4,000 wild equine. The results obtained 
by testing the anthelmintic medication on these free resistance strongyls may be use for 
reference data in order to calculate the resistance factor 
  
MATERIALS AND METHODS 
 
In order to test various anthelmintic acting on equine strongyls between in November 
2008 - April 2009, have been tested Ivermectine (IVM), Fenbendazole (FBZ) and 
Mebendazole (MBZ). Strongyls eggs originated from a total of 126 faecal samples collected 
during the 6 months of study, from three different areas of the Danube Delta (Maliuc, 
Mahmudia and Crisan), where it is estimated that there are a number of over 4,000 wild 
equine. In order to determine the number of eggs/g of faecal (EPG) was performed Mc Master 
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method. From samples were also made faecal-culture in order to identify the strongyl species, 
based on morphology of the third stage larva (L3) [Cernea et al., 2008]. The in vitro test was 
performed for MBZ, FBZ and IVM by using larva development assay (LDA). Were used 11 
serial dilutions between 5-0.0049µg/ml for FBZ and MBZ. For IVM were used 11 serial 
dilution from 0.012 to 0.000011µg/ml. Calculation of reference parameters was performed 
using Anthelmintic Resistance Program (ARP) software provided by www.pharma-logic.ro. 
Using this soft we was able to calculate the rate of larval development, prediction line and its 
equation; lethal concentration (LC) 50, 90 and 100 and minimum inhibitory concentration 
(MIC). The total number of measurements and analysis for the substances tested was 228, 
including the statistical analysis for each sample separately. 
 
RESULTS AND DISCUSSIONS 
 
Testing Fenbendazole by using LDA revealed that the first developed L3 were at 
concentration of 1.25µg/ml after 12 days of incubation, percentage of development being 50% 
(table 1). The maximum percentage of development (100%) was recorded at concentration of 
0.0195µg/ml and 0.0098µg/ml, while the media of control samples with water and 
hydrochloric acid was 90%. Statistical analysis performed for FBZ test showed that the a 
parameter were -54.49 and b 49.50. MIC calculation revealed -18.6031µg/ml, reflecting a 
very good action of FBZ against development of strongyls larvae (table 1). 
 
Tab.1 
Results and reference parameters for the FBZ test obtained by LDA for the equine from Danube Delta 
(November 2008 - April 2009) 
Sample  
no. 





1 100 0 5,0000 0,00 -222,95 
2 150 0 2,5000 0,00 -86,73 
3 50 50 1,2500 50,00 -18,61 
4 50 0 0,6250 0,00 15,44 
5 200 0 0,3125 0,00 32,47 
6 100 50 0,1563 33,33 40,98 
7 50 0 0,0781 0,00 45,24 
8 100 50 0,0391 33,33 47,37 
9 0 50 0,0195 100,00 48,44 
10 0 50 0,0098 100,00 48,97 
11 50 0 0,0049 0,00 49,23 
M1 - H2O 0 150 - 90,00 49,50 
M2 - HCL 50 200 - 80,00 49,50 
Parameter a -54,49 LC 50 0,0089 
Parameter b 49,50 LC 90 -0,7430 
MIC µg/ml -18,6031 LC 100 -0,9265 
M1 = control sample with water; M2 = control sample with hydrochloric acid; L1 and L2 = strongyls larva in the 
first and second stage of development 
 
Negative value of MIC reflects the high effectiveness of FBZ. Achieving a positive 
value for MIC is not justified in practice because they would be engaged to carry out dilution 
of less than 0.0049µg/ml. Because the MIC was calculated on equine populations that have 
not received any anthelmintic treatment we recommend this value as reference for all other 
resistance tests with FBZ. In practical terms, if the other resistance tests with FBZ will obtain 
MIC greater than those -18.6031µg/ml, than the tested strongyls populations must considerate 
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as presenting the risk of developing genetic changes that allow the resistance to this 
anthelmintic. Effectiveness of FBZ was confirmed also by low values of lethal concentrations 
LC50 0.0089µg/ml, while the LC100 was -0.9265µg/ml (table 1). Calculating the prediction 
line revealed that the minimum Y was -222.95. 
 
Testing the Mebendazole effectiveness highlighted the emergence of L3 from the 
concentration of 0.3125µg/ml, the maximum rate of development were to the concentration of 
0.0391 and 0.0195µg/ml. Therefore the parameter a was -89.11 and the parameter b 49.30. 
These values were determined a MIC of 21.4542µg/ml, value which is approximately two 
times higher than that obtained from FBZ (table 2). Because the MIC was calculated on 
strongyls populations presumed to be free of resistance phenomena, we consider it to be used 
as reference concentration in future MBZ tests applied to other equine populations which 
present the risk of resistance installation. Calculation of LC50 by using ARP determinate a 
value of -0.0078µg/ml, which is inferior to FBZ result. In contrast with results obtained in 
FBZ test, the prediction line trend for MBZ is much less pronounced towards ∞, the minimum 
value of the parameter Y reaching -396.25 (table 2). These data show that efficacy is higher 
for MBZ if prolonged period of contact with intestinal strongyls and may therefore be 
advisable for the administration of successive daily doses compared with a single dose. 
 
Tab. 2 
Results and reference parameters for the MBZ test obtained by LDA for the equine from Danube Delta 
(November 2008 - April 2009) 
Sample  
no. 





1 150 0 5,0000 0,00 -396,25 
2 200 0 2,5000 0,00 -173,48 
3 100 0 1,2500 0,00 -62,09 
4 100 0 0,6250 0,00 -6,39 
5 50 50 0,3125 50,00 21,45 
6 100 50 0,1563 33,33 35,37 
7 100 50 0,0781 33,33 42,34 
8 0 50 0,0391 100,00 45,82 
9 0 50 0,0195 100,00 47,56 
10 50 10 0,0098 16,67 48,43 
11 100 0 0,0049 0,00 48,86 
M1 - H2O 0 150 - 90,00 49,30 
M2 - HCL 50 200 - 80,00 49,30 
Parameter a -89,11 LC 50 -0,0078 
Parameter b 49,30 LC 90 -0,4566 
MIC µg/ml 21,4542 LC 100 -0,5688 
M1 = control sample with water; M2 = control sample with hydrochloric acid; L1 and L2 = strongyls larva in the 
first and second stage of development 
 
In order to testing other anthelmintic drugs, from the group of macrocyclic lactone 
was chosen Ivermectine. Were prepared 11 serial dilution, from 0.012µg/ml to 
0.000011µg/ml. The samples were kept in the incubator at 260C for 12 days. Following the 
analysis of results was noted that the percentage of development was zero and obtained only 
at 3 concentrations, namely 0.012µg/ml, 0.0015µg/ml and 0.000023µg/ml. The maximum 
percentage of hatching was recorded at concentration of 0.00075µg/ml which would indicate 
a reduced efficacy of IVM on exogenous strongyls stage. The hatching percentage to control 




Results and reference parameters for the IVM test obtained by LDA for the equine from Danube Delta 
(November 2008 - April 2009) 
Sample  
no. 





1 100 0 0,012000 0,00 -536,30 
2 50 100 0,006000 66,67 -250,01 
3 50 50 0,003000 50,00 -106,87 
4 100 0 0,001500 0,00 -35,30 
5 0 50 0,000750 100,00 0,48 
6 100 0 0,000375 0,00 18,38 
7 100 50 0,000188 33,33 27,32 
8 100 50 0,000093 33,33 31,83 
9 50 50 0,000046 50,00 34,08 
10 50 0 0,000023 0,00 35,17 
11 50 50 0,000011 50,00 35,75 
M - H2O 50 250 - 41,67 36,27 
Parameter a -47713,83 LC 50 -0,00028 
Parameter b 36,27 LC 90 0,0011 
MIC µg/ml -250,004 LC 100 0,0013 
M = control sample with water; L1 and L2 = strongyls larva in the first and second stage of development 
 
By the statistical interpreting of results the a parameter has a very small value             
(-47713.83), while the b parameter reached 37.27. Because the first L3 were observed on the 
concentration of 0.06µg/ml, the minimal inhibitory concentration value was -250.004µg/ml 
which indicates a very good efficacy of IVM against strongyls larvae. This effectiveness was 
confirmed by mathematical calculation of LC, where we obtained values LC50 -0.00028µg/ml, 
LC90 0.0011µg/ml and LC100 0.0013µg/ml. Graphical representation of the equation line 
revealed that it had the lowest Y compared with those obtained from benzimidazole testing. 
Thus Y has the value of -536.30 at concentration 0.012µg/ml and 35.75 to the concentration 
of 0.000011µg/ml (table 3). 
 
Considering the results obtained by testing the 3 anthelmintic substances on the 
strongyls eggs and larva from wild equine populations from Danube Delta, we can conclusion 
that all medicinal substances had a good efficacy on these parasites. From pharmaceutical 
point of view, this result is normal for the equine have never benefited from any anthelmintic 
treatment. The obtained data can be used as references for calculating the resistance factor to 
other equine populations in order to verify the efficacy or resistance to the medication. 
Base on morphostructural aspects of the L3 strongyls stage of development, offered 
the chance to identifying and calculate the proportion between different species, especially in 
population that has not intervened with anthelmintic medication. This is particularly important 
because many worldwide studies show that the anthelmintic treatments affect considerable the 
reduction of large strongyls correlated with a recrudescence of small strongyls species 
(Cyathostomum spp.) of [Madeira de Carvalho, 2001]. Currently Cyathostomum spp. are 
considered the most significant pathogenic in horses. This explains the many studies of these 
species (biology and species identification) and the results are an innovative control programs 
to combat these disease [Lyons and Drudge, 1999; Cernea, 2007]. 
Analysis of strongyls population structure in the equine from Danube Delta revealed 
substantial predominance of small strongyls species (Cyathostominae). This represents 
84.40% (Cyathostomum spp. with 82.10% and Poteriostomum spp. with 2.30%) of total 
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species. Difference was represented by large strongyls (Strongylinae), especial Strongylus 
vulgaris (10.10%), than Strongylus equinus with 0.40%, Strongylus edentatus with 3.05% and 




Research conducted during November 2008 - April 2009, on samples from the wild 
equine of the Danube Delta for the purpose of determining the reference parameters required 
for testing drug resistance to anthelmintic acting on hors strongyls revealed the following 
aspects:  
 
1. By LDA test the reference lethal concentrations for Fenbendazole were: 0.0089µg/ml 
for LC50, -0.7430µg/ml for LC90 and -0.9265µg/ml for LC100, with a MIC of -18.6031 
µg/ml. 
2. For Mebendazole the reference lethal concentrations were: -0.0078µg/ml for LC50,         
-0.4566µg/ml for LC90 and -0.5688µg/ml for LC100, with a MIC of 21.4542µg/ml. 
3. For Ivermectin the reference lethal concentrations were -0.00028µg/ml for LC50, 
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